Rescue of ICSI failure in non-obstructive azoospermia by switching from cryopreserved to fresh testicular sperm: a paired clinical analysis

Non-obstructive azoospermia (NOA) is a severe form of male infertility. Although cryopreserved testicular sperm are widely used for intracytoplasmic sperm injection (ICSI), a subset of patients experience poor outcomes with a specific frozen-thawed sample. This study aimed to evaluate whether obtaining fresh testicular sperm via repeat mTESE could serve as a rescue strategy for NOA patients with prior poor or failed ICSI outcomes using cryopreserved sperm. This retrospective paired clinical study included 20 men with NOA who underwent microdissection testicular sperm extraction (mTESE) and two ICSI cycles between December 2019 and February 2024 at a tertiary reproductive center. Each patient first underwent ICSI using cryopreserved-thawed testicular sperm, followed by a second ICSI cycle using fresh testicular sperm. Fertilization rate, 2PN rate, number of available embryos, clinical pregnancy rate, and live birth rate were compared between paired cycles using appropriate statistical tests.As a rescue-focused paired design, this cohort was intentionally enriched for patients with poor first-cycle outcomes and therefore does not represent an unselected NOA population. Switching to fresh testicular sperm significantly improved fertilization rate (86.7% vs. 62.7%, P = 0.0045), number of available embryos (3.50 ± 2.24 vs. 1.05 ± 0.60, P = 0.0005), clinical pregnancy rate (55.0% vs. 15.0%, P = 0.021), and live birth rate (45.0% vs. 5.0%, P = 0.008). The 2PN rate was higher but not statistically significant (79.5% vs. 68.5%, P = 0.094). Progressive motility sperm were more frequent in fresh samples (75% vs. 20%, P = 0.0003). No adverse events occurred. In NOA patients with prior poor or failed ICSI outcomes using cryopreserved testicular sperm, repeating mTESE to obtain fresh sperm was associated with significantly improved fertilization and pregnancy outcomes. These findings support fresh testicular sperm as an individualized rescue option rather than evidence of universal superiority over cryopreserved sperm in the general NOA population.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-04-22
DOI
https://doi.org/10.1038/s41598-026-42481-4
Primary Topic
Sperm and Testicular Function
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rescue of ICSI failure in non-obstructive azoospermia by switching from cryopreserved to fresh testicular sperm: a paired clinical analysis

Huaye Chen, Li Qi, Tingting Wu, Yanhua Huang et al.
Scientific Reports
Sperm and Testicular Function
article

Rescue of ICSI failure in non-obstructive azoospermia by switching from cryopreserved to fresh testicular sperm: a paired clinical analysis

Huaye Chen, Li Qi, Tingting Wu, Yanhua Huang, Yanlin Ma, Lingxiao Zhang
article en

Abstract

Non-obstructive azoospermia (NOA) is a severe form of male infertility. Although cryopreserved testicular sperm are widely used for intracytoplasmic sperm injection (ICSI), a subset of patients experience poor outcomes with a specific frozen-thawed sample. This study aimed to evaluate whether obtaining fresh testicular sperm via repeat mTESE could serve as a rescue strategy for NOA patients with prior poor or failed ICSI outcomes using cryopreserved sperm. This retrospective paired clinical study included 20 men with NOA who underwent microdissection testicular sperm extraction (mTESE) and two ICSI cycles between December 2019 and February 2024 at a tertiary reproductive center. Each patient first underwent ICSI using cryopreserved-thawed testicular sperm, followed by a second ICSI cycle using fresh testicular sperm. Fertilization rate, 2PN rate, number of available embryos, clinical pregnancy rate, and live birth rate were compared between paired cycles using appropriate statistical tests.As a rescue-focused paired design, this cohort was intentionally enriched for patients with poor first-cycle outcomes and therefore does not represent an unselected NOA population. Switching to fresh testicular sperm significantly improved fertilization rate (86.7% vs. 62.7%, P = 0.0045), number of available embryos (3.50 ± 2.24 vs. 1.05 ± 0.60, P = 0.0005), clinical pregnancy rate (55.0% vs. 15.0%, P = 0.021), and live birth rate (45.0% vs. 5.0%, P = 0.008). The 2PN rate was higher but not statistically significant (79.5% vs. 68.5%, P = 0.094). Progressive motility sperm were more frequent in fresh samples (75% vs. 20%, P = 0.0003). No adverse events occurred. In NOA patients with prior poor or failed ICSI outcomes using cryopreserved testicular sperm, repeating mTESE to obtain fresh sperm was associated with significantly improved fertilization and pregnancy outcomes. These findings support fresh testicular sperm as an individualized rescue option rather than evidence of universal superiority over cryopreserved sperm in the general NOA population.

Scientific Reports
Hainan Modern Women and Children's Hospital (CN), Hainan Medical University (CN)
Hainan Medical University
Zero hunger
Openalex Percentile: Top 7%
Sperm and Testicular Function
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.